[{"Assets_0_Q2_USD":388592000.0,"CommonStockSharesOutstanding_0_Q2_shares":36677608.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":93605000.0,"NetIncomeLoss_1_Q2_USD":11153000.0,"NetIncomeLoss_2_Q2_USD":-16017000.0,"StockholdersEquity_0_Q2_USD":118404000.0,"EarningsPerShareBasic_1_Q2_USD":0.3,"EarningsPerShareBasic_2_Q2_USD":-0.46,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":36610918.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":34990989.0,"Ticker":"VYGR","CIK":"1640266","name":"VOYAGER THERAPEUTICS, INC.","OfficialName":"Voyager Therapeutics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"363614047.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190809"}]